Literature DB >> 30995506

Shared and Distinct Functions of Type I and Type III Interferons.

Helen M Lazear1, John W Schoggins2, Michael S Diamond3.   

Abstract

Type I interferons (IFNs) (IFN-α, IFN-β) and type III IFNs (IFN-λ) share many properties, including induction by viral infection, activation of shared signaling pathways, and transcriptional programs. However, recent discoveries have revealed context-specific functional differences. Here, we provide a comprehensive review of type I and type III IFN activities, highlighting shared and distinct features from molecular mechanisms through physiological responses. Beyond discussing canonical antiviral functions, we consider the adaptive immune priming, anti-tumor, and autoimmune functions of IFNs. We discuss a model wherein type III IFNs serve as a front-line defense that controls infection at epithelial barriers while minimizing damaging inflammatory responses, reserving the more potent type I IFN response for when local responses are insufficient. In this context, we discuss current therapeutic applications targeting these cytokine pathways and highlight gaps in understanding of the biology of type I and type III IFNs in health and disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30995506      PMCID: PMC6839410          DOI: 10.1016/j.immuni.2019.03.025

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  223 in total

1.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.

Authors:  Mikhail B Litinskiy; Bernardetta Nardelli; David M Hilbert; Bing He; Andras Schaffer; Paolo Casali; Andrea Cerutti
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

Review 2.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.

Authors:  Laura J Yockey; Akiko Iwasaki
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

3.  Zika virus inhibits type-I interferon production and downstream signaling.

Authors:  Anil Kumar; Shangmei Hou; Adriana M Airo; Daniel Limonta; Valeria Mancinelli; William Branton; Christopher Power; Tom C Hobman
Journal:  EMBO Rep       Date:  2016-10-24       Impact factor: 8.807

4.  Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells.

Authors:  Se-Jung Lee; Wun-Jae Kim; Sung-Kwon Moon
Journal:  Int J Mol Med       Date:  2012-07-16       Impact factor: 4.101

5.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

Review 6.  25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.

Authors:  Markus H Heim
Journal:  Nat Rev Immunol       Date:  2013-06-07       Impact factor: 53.106

7.  Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model.

Authors:  Uma M Nagarajan; Daniel Prantner; James D Sikes; Charles W Andrews; Anna M Goodwin; Shanmugam Nagarajan; Toni Darville
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

8.  IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.

Authors:  Pamela I Osterlund; Taija E Pietilä; Ville Veckman; Sergei V Kotenko; Ilkka Julkunen
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

9.  Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

Authors:  Shekar Srinivas; Jihong Dai; Joyce Eskdale; Grant E Gallagher; Nicholas J Megjugorac; Grant Gallagher
Journal:  Immunology       Date:  2008-06-10       Impact factor: 7.397

10.  Impairment of T and B cell development by treatment with a type I interferon.

Authors:  Q Lin; C Dong; M D Cooper
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  263 in total

1.  Decoding the Body Language of Immunity: Tackling the Immune System at the Organism Level.

Authors:  Nicolas Chevrier
Journal:  Curr Opin Syst Biol       Date:  2019-11-06

Review 2.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation.

Authors:  Hao Zhou; Michelle Møhlenberg; Ewa Terczyńska-Dyla; Kasper Grønbjerg Winther; Nanna Hougaard Hansen; Johan Vad-Nielsen; Laura Laloli; Ronald Dijkman; Anders Lade Nielsen; Hans Henrik Gad; Rune Hartmann
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 4.  New immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response.

Authors:  Huie Jing; Helen C Su
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

5.  The role of type 1 interferons in coagulation induced by gram-negative bacteria.

Authors:  Xinyu Yang; Xiaoye Cheng; Yiting Tang; Xianhui Qiu; Zhongtai Wang; Guang Fu; Jianfeng Wu; Haixia Kang; Jing Wang; Haichao Wang; Fangping Chen; Xianzhong Xiao; Timothy R Billiar; Ben Lu
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

6.  Viral infection dampens human fetal membrane type I interferon responses triggered by bacterial LPS.

Authors:  Julie A Potter; Mancy Tong; Paulomi Aldo; Ja Young Kwon; Mary Pitruzzello; Gil Mor; Vikki M Abrahams
Journal:  J Reprod Immunol       Date:  2020-04-08       Impact factor: 4.054

Review 7.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257

8.  Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.

Authors:  Rishi R Goel; Xinghao Wang; Liam J O'Neil; Shuichiro Nakabo; Kowser Hasneen; Sarthak Gupta; Gustaf Wigerblad; Luz P Blanco; Jeffrey B Kopp; Maria I Morasso; Sergei V Kotenko; Zu-Xi Yu; Carmelo Carmona-Rivera; Mariana J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

9.  Lymphatic Type 1 Interferon Responses Are Critical for Control of Systemic Reovirus Dissemination.

Authors:  Matthew B Phillips; Marcelle Dina Zita; Morgan A Howells; Tiffany Weinkopff; Karl W Boehme
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

10.  MDA5 Is an Essential Sensor of a Pathogen-Associated Molecular Pattern Associated with Vitality That Is Necessary for Host Resistance against Aspergillus fumigatus.

Authors:  Xi Wang; Alayna K Caffrey-Carr; Ko-Wei Liu; Vanessa Espinosa; Walburga Croteau; Sourabh Dhingra; Amariliz Rivera; Robert A Cramer; Joshua J Obar
Journal:  J Immunol       Date:  2020-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.